| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02598310 Details | 2019-08-28 Interventional | 2 | - | Paclitaxel Trastuzumab Breast Neoplasm… Breast Cancer Estrogen Recept… HER-2 Positive … | - - | |||
| NCT02438787 2015-000288-16 Details | 2019-08-28 Interventional | 3 | 315 | Golimumab Ustekinumab Axial Spondyloa… Spondylarthriti… Spondylitis | This study was stopped because ustekinumab did not achieve key endpoints in a related study.
The safety profile was consistent with past ustekinumab studies. The study was discontinued before it was fully enrolled due to lack of efficacy of either dose of ustekinumab in the CNTO1275AKS3001 (NCT02437162) study. | |||
| NCT02437162 2014-003679-48 Details | 2019-08-28 Interventional | 3 | 347 | Golimumab Ustekinumab Axial Spondyloa… Spondylarthriti… Spondylitis | Neither dose achieved the study's primary or major secondary endpoints. The safety profile was
consistent with previous ustekinumab studies. The study was terminated since neither dose achieved the study's primary or major secondary endpoints. | |||
| NCT02054338 2006-001139-23 Details | 2019-08-28 Interventional | 3 | 1004 | Gemcitabine Paclitaxel Breast Neoplasm… Advanced Breast… | Study was stopped before progressive disease or death of alive subjects. None reported | |||
| NCT02013375 Details | 2019-08-28 Interventional | 2 | 2 | Alemtuzumab Cyclophosphamid… Sirolimus Anemia, Sickle … Sickle Cell Dis… | - - | |||
| NCT01189409 Details | 2019-08-28 Interventional | 4 | 70 | Sennosides Constipation Opioid-Induced … Cancer | This study was terminated based on results of interim analysis. - | |||
| NCT01090414 Details | 2019-08-28 Interventional | 1/2 | [28 Refs] | 202 | Idelalisib Leukemia, Lymph… Leukemia, Lymph… Lymphoma, Non-H… Chronic Lymphoc… | - - | ||
| NCT01016262 Details | 2019-08-28 Interventional | 3 | 119 | Mesalamine Proctitis Ulcer Proctitis, Ulce… | The decision was taken solely for business/administrative reasons, no safety considerations
entered into this. Ongoing randomized patients to complete. The study was terminated because of business/administrative reasons and not because of safety considerations. | |||
| NCT00167206 Details | 2019-08-26 Interventional | 1/2 | 16 | Cyclophosphamid… Fludarabine Anemia Fanconi Anemia Fanconi Syndrom… | Treatment with thymic shielding found safe, another study started. Study ended early as thymic shielding was found to be safe. Therefore, a new study was designed using thymic shielding. | |||
| NCT03232307 Details | 2019-08-22 Interventional | 2 | 0 | Antibodies Antibodies, Mon… Antineoplastic … BB 1101 Dexamethasone Dexamethasone a… Ibrutinib Immunoglobulins Lenalidomide Rituximab Lymphoma Lymphoma, Mantl… CCND1 Positive CD20-Positive N… Mantle Cell Lym… | Sponsor does not wish to proceed - | |||
| NCT03726281 Details | 2019-08-21 Interventional | 2 | 0 | Nivolumab Neoplasms, Germ… Germ Cell Tumor… | End of Agreement between BMS and SGHL - | |||
| NCT03395873 Details | 2019-08-21 Interventional | 1 | 7 | Avelumab Decitabine Acute Myeloid L… | Recent FDA approval of a new drug for the same patient population - | |||
| NCT02275806 Details | 2019-08-21 Interventional | 2 | 4 | Camptothecin Irinotecan Carcinoma, Non-… Lung Neoplasms Lung Neoplasms,… | PI decided to terminate study - | |||
| NCT00836069 Details | 2019-08-21 Interventional | 3 | 5 | Paroxetine Anxiety Disorde… | Pfizer has terminated the execution of this protocol - | |||
| NCT03226080 Details | 2019-08-20 Interventional | 4 | 0 | Rocuronium Fractures, Bone Hip Fractures Anesthesia, Gen… Anesthesia, Spi… Neuromuscular B… | Study terminated with IRB on 20Feb2019 due to lack of enrollment. - | |||
| NCT03031340 Details | 2019-08-20 Interventional | 3 | 3 | Pregabalin Spinal Fusion | Incidence of AE - | |||
| NCT02871323 Details | 2019-08-20 Interventional | 1 | 0 | Antibodies, Mon… Durvalumab Immunoglobulin … Immunoglobulins Polycythemia Polycythemia Ve… Primary Myelofi… Polycythemia Ve… | PI decided to withdraw the study after it opened for enrollment but before any patients were
enrolled - | |||
| NCT02605824 Details | 2019-08-20 Interventional | 4 | 1 | Acetylcysteine N-monoacetylcys… Asthma | The study was closed after we determined that this albuterol/NAC regimen may be associated with
excessive bronchoconstriction. - | |||
| NCT02196207 Details | 2019-08-20 Interventional | 3 | 0 | Antibodies, Bis… Hemophilia A Severe Hemophil… | The trial was revised to be two protocols, one Prevention, one Eradication Trials. - | |||
| NCT01539291 2011-006293-72 Details | 2019-08-20 Interventional | 3 | [3 Refs] | 161 | Idelalisib Leukemia Leukemia, Lymph… Leukemia, Lymph… Chronic Lymphoc… | - - |